4D Molecular Therapeutics, Inc.
USD13.66
+0.79 (+6.09%)
CEO
David H. Kirn
IPO Date
2020-12-11
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$12.87
Prev. Close
$12.88
Day Low
$12.69
Day High
$13.73
52W Low
$3.68
52W High
$13.73
Market Cap
$0.71B
Volume
0.25M
| -1.9 |
| 31 Dec 2023 | FY | -368.5% | -486.6% | -32.8% | -29.7% | 0.05 | 15.65 | -7.9 |
| 31 Dec 2022 | FY | -2464.8% | -3435.4% | -46.5% | -41.1% | 0.07 | 14.02 | -6.7 |
| 31 Dec 2021 | FY | -240.2% | -395.4% | -22.3% | -20.2% | 0.05 | 15.69 | -8.5 |
| 31 Dec 2020 | FY | -289.6% | -416.5% | -22.1% | -19.7% | 0.00 | 16.88 | -19.5 |
| 31 Dec 2019 | FY | -454.2% | -705.8% | 67.6% | -84.7% | 0.00 | 4.05 | -21.8 |
| 31 Dec 2018 | FY | -30.0% | -67.6% | 34.6% | -9.8% | 0.00 | 11.68 | -53.1 |
| 31 Dec 2017 | FY | -134.4% | -193.8% | 57.3% | -41.1% | 0.00 | 4.15 | -53.5 |
| 5.6 |
| 30 Sept 2025 | Q3 | -52386.7% | -63195.6% | -15.4% | -13.4% | 0.06 | 8.42 | -2.1 |
| 30 Jun 2025 | Q2 | -319573.3% | -364386.7% | -13.0% | -11.5% | 0.05 | 8.75 | -0.9 |
| 31 Mar 2025 | Q1 | 100.0% | -342657.1% | -10.2% | -9.3% | 0.05 | 12.36 | -0.9 |
| 31 Dec 2024 | Q4 | -178300.0% | -4967100.0% | -9.7% | -8.9% | 0.05 | 14.92 | -1.5 |
| 30 Sept 2024 | Q3 | 100.0% | -1461433.3% | -7.9% | -7.3% | 0.04 | 17.33 | -3.4 |
| 30 Jun 2024 | Q2 | -637100.0% | -699060.0% | -5.9% | -5.6% | 0.02 | 28.48 | -8.4 |
| 31 Mar 2024 | Q1 | -99435.7% | -115717.9% | -5.4% | -5.1% | 0.02 | 32.65 | -11.4 |
| 31 Dec 2023 | Q4 | 137089.5% | 169910.5% | -10.5% | -9.5% | 0.05 | 15.65 | -6.1 |